国际药物开发与研究杂志

  • 国际标准期刊号: 0975-9344
  • 期刊 h 指数: 44
  • 期刊引用分数: 59.93
  • 期刊影响因子: 48.80
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

In Silico Docking of Polyphenolic Compounds against Caspase 3-HeLa Cell Line Protein

Ashwini S, Shine P Varkey and Manjula Shantaram

The present study was carried out using caspase 3, which is a human cervical cancer cell line protein. The current molecular docking shall stand useful for designing and development of future novel compound with higher inhibitory activity against caspase 3-HeLa protein. Further, these compounds can be validated further in wet lab to be nominated as potential drug candidates against HeLa proteins. The highest negative energy value obtained after docking among five compounds with caspase 3 was found to be coumarin (-378.3 KJ/mol), followed by camptothecin, epigallocatechin and quercetin with docking scores -285.3, -258.2 and -236 KJ/mol respectively. The least docking score was in docking of gallic acid with caspase3 and the scoring was -181.3 using Hex 8.0.0 docking software.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证